-
A Peek Into The Market Before The Trading Starts
Wednesday, October 20, 2010 - 7:47am | 473Read More...Pre-open movers US stock futures moved up, as investors are awaiting another round of earnings from several major companies today. Futures for the Dow Jones Industrial Average gained 20 points to 10,963.00, while those for the S&P 500 rose 4 points to 1,167.80. Futures for the Nasdaq 100 moved...
-
Oppenheimer & Co Downgrades KEY To Perform
Wednesday, October 13, 2010 - 6:58am | 39Read More...Analysts at Oppenheimer & Co downgrade KeyCorp (NYSE: KEY) from "outperform" to "perform." KEY's shares gained 0.24% to close at $8.50 yesterday. More Analyst Ratings here
-
A Peek Into The Market Before The Trading Starts
Thursday, September 30, 2010 - 8:20am | 499Read More...Pre-open movers US stock futures moved down slightly, after disappointing news from Ireland and Spain. The jobs data of Germany offset some of the decline in Europe. Futures on the Dow Jones Industrial Average fell 4 points to 10,776. S&P 500 futures dropped 2.20 points to 1,139 and Nasdaq 100...
-
A Peek Into The Market Before The Trading Starts
Tuesday, September 21, 2010 - 8:43am | 472Read More...Pre-open movers US futures were mixed as the investors moved to the sidelines, awaiting the Federal Reserve decision on the monetary policy, today. Futures on the Dow Jones Industrial Average rose 7 points to 10,678 and S&P 500 futures moved down 1.20 points to 1,135. Nasdaq 100 futures gained...
-
A Peek Into The Market Before The Trading Starts
Tuesday, September 14, 2010 - 9:15am | 515Read More...Pre-open movers US stock futures were mixed, as investors were cautious after the gains in the earlier session. Futures for the Dow Jones Industrial Average fell 2 points to 10,470, while those for the S&P 500 lost 1.30 points to 1,114.90. Futures for the Nasdaq 100 gained 0.50 points to 1,917....
-
A Peek Into The Market Before The Trading Starts
Friday, September 3, 2010 - 9:02am | 470Read More...Pre-open movers US stock futures remained range bound on Friday, ahead of the government's monthly employment report. Futures for the Dow Jones Industrial Average fell 11 points to 10,298. S&P 500 futures gained 0.4 points to 1,090, while Nasdaq 100 index futures rose 2.75 to 1,840. A Peek...
-
ALIM: FDA Grants Iluvien NDA Priority Review
Tuesday, August 31, 2010 - 9:11am | 173Read More...Analysts at Oppenheimer & Co reiterate their "outperform" rating on Alimera Sciences (NASDAQ: ALIM), while raising their estimates for the company. The target price for ALIM is set to $16 According to Oppenheimer & Co, “On 8/30, the FDA granted priority review of ALIM's NDA for Iluvien for...
-
Court Denies SKH’s Motion For Mistrial
Monday, August 30, 2010 - 11:08am | 165Read More...Analysts at Oppenheimer & Co reiterate their "outperform" rating on Skilled Healthcare Group (NYSE: SKH). The target price for SKH is set to $10. According to Oppenheimer & Co, “The Humboldt County Court in California has denied Skilled Healthcare's previously filed Motion for Mistrial or...
-
Florida Settlement Boosts NEE’s Estimates
Monday, August 23, 2010 - 9:08am | 129Read More...Analysts at Oppenheimer & Co reiterate their "outperform" rating on NextEra Energy Inc (NYSE: NEE), while raising their estimates for the company. The target price for NEE has been raised from $56 to $58. Oppenheimer & Co says, “Our FY11 EPS estimate increases as FPL receives some recovery...
-
Oppenheimer Believes JKHY Has Strong Near-Term Earnings Visibility
Thursday, August 19, 2010 - 9:22am | 199Read More...Analysts at Oppenheimer & Co reiterate their "perform" rating on Jack Henry (NASDAQ: JKHY), while reducing their estimates for the company. According to Oppenheimer & Co, “Integration of Pemco, Goldleaf and iPay remain on plan and management reiterated the expected earnings accretion from...
-
CHTP: Midodrine Withdrawal Likely; Could Improve Droxidopa Opportunity If Ph.3s Work
Tuesday, August 17, 2010 - 10:20am | 161Read More...Analysts at Oppenheimer & Co reiterate their "perform" rating on Chelsea Therapeutics (NASDAQ: CHTP). According to Oppenheimer & Co, “On 8/16, consistent with prior warnings, the FDA officially proposed to withdraw approval for branded and generic midodrine, currently labeled for NOH—the...
-
Increased Scale Leaves EQIX In Dominant Market Position
Thursday, July 29, 2010 - 10:36am | 139Read More...Analysts at Oppenheimer & Co upgrade Equinix Inc (NASDAQ: EQIX) from "perform" to "outperform," while reducing their estimates for the company. The target price for EQIX is set to $115. According to Oppenheimer & Co, “Our more constructive stance on EQIX shares is predicated on the...
-
ZRAN Facing Fresh And Persistent Challenges
Tuesday, July 27, 2010 - 10:28am | 186Read More...Analysts at Oppenheimer & Co reiterate their "outperform" rating on Zoran Corporation (NASDAQ: ZRAN), while reducing their estimates for the company. The target price for ZRAN has been reduced to $11. According to Oppenheimer & Co, “In a replay of 1Q10, Zoran met downbeat quarterly targets...
-
ATHR: PC Market Cracks Grow More Evident
Tuesday, July 20, 2010 - 2:18pm | 131Read More...Analysts at Oppenheimer & Co maintain their "perform" rating on Atheros Communications (NASDAQ: ATHR), while raising their estimates for the company. According to Oppenheimer & Co, “ATHR reported EPS of $0.67 on revs of $238M vs. the Street's $0.64/$236M. Outlook for EPS of $0.68 on revs of...
-
Investor Reaction To Remain Muted After AMD Results
Friday, July 16, 2010 - 2:30pm | 153Read More...Analysts at Oppenheimer & Co reiterate their "underperform" rating on Advanced Micro Devices (NYSE: AMD), while raising their estimates for the company. According to Oppenheimer & Co, “After the close, AMD reported solid 2Q sales/non-GAAP EPS of $1.65B/$0.12; Street estimates were $1.55B/$0...
